Epstein-barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment

Clinical Cancer Research

Volumn 19, Issue 8, 2013, Pages 2175-2186

  Adham, Marlinda ^a   Greijer, Astrid E ^c   Verkuijlen, Sandra A W M ^c   Juwana, Hedy ^c   Fleig, Sabine ^c   Rachmadi, Lisnawati ^a   Malik, Octavia ^c   Kurniawan, A N ^a   Roezin, Averdi ^a   Gondhowiardjo, Soehartati ^a   Atmakusumah, Djumhana ^a   Stevens, Servi J C ^c   Hermani, Bambang ^a   Bing Tan, I ^b   Middeldorp, Jaap M ^c  

^a CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; IMMUNOGLOBULIN A; VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE PROCEDURE; MULTIPLE CYCLE TREATMENT; NASOPHARYNGEAL BRUSHING; NASOPHARYNX CARCINOMA; NONHUMAN; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPEAT PROCEDURE; RESPIRATORY TRACT EXAMINATION; SCHOOL CHILD; SEROLOGY; VIRUS LOAD;

ADOLESCENT; ADULT; CHEMORADIOTHERAPY; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EARLY DIAGNOSIS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84877089132     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-2897     Document Type: Article

References (35)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Vol. VIII. Lyon, France: IARC Scientific Publications; 2002. p. 1-781.
2. Soeripto. Epidemiology of nasopharyngeal carcinoma. Berita Kedokteran Masyarakat 1998;XIII:207-11.
3. Adham M, Kurniawan AN, Muhtadi A, Roezin A, Hermani B, Gondhowiardjo S, et al. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs and symptoms at presentation. Chin J Cancer 2012;31:185-96.
4. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005;61:1107-16. (Pubitemid 40340904)
5. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, non-keratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus infected neoplasia. Am J Pathol 1995;146:1355-67.
6. Nam J, McLaughlin JK, Blot WJ. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among U.S. whites. J Natl Cancer Inst 1992;84:619-22.
7. Nicholls JM, Agathangelou A, Fung K, Zeng X, Niedobitek G. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma. J Pathol 1997;183:164-8. (Pubitemid 27436019)
8. Low WK. The contact bleeding sign of nasopharyngeal carcinoma. Head Neck 1997;19:617-9. (Pubitemid 27407317)
9. Waldron J, Hasselt AV, Wong RKY. Sensitivity of biopsy using local anesthesia in detecting nasopharyngeal carcinoma. Head Neck 1992;14:24-7.
10. Pak MW, O KF, Leung SF, Van Hasselt CA. In vivo diagnosis of nasopharyngeal carcinoma using contact rhinoscopy. Laryngoscope 2001;111:1453-8. (Pubitemid 32730194)
11. Sham JST, Wei WI, Kwan WH, Chan CW, Choi PHK, Choy D. Fiberoptic endoscopic examination and biopsy in determining the extent of nasopharyngeal carcinoma. Cancer 1989;64:1838-42. (Pubitemid 19267801)
12. Sheen TS, Ko JY, Chang YL, Chang YS, Huang YT, Chang Y, et al. Nasopharyngal swab and PCR for the screening of nasopharyngeal carcinoma in the endemic area: a good supplement to the serologic screening. Head Neck 1998;20:732-8. (Pubitemid 28462830)
13. Tune CE, Liavaag PG, Freeman JL, Van den Brekel MWM, Spitzer T, Kerrebijn JDF, et al. Nasopharyngeal brush biopsies and detection of nasopharyngeal cancer in a high risk population. J Natl Cancer Inst 1999;91:796-80.
14. Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Paramita DK, Fachiroh J, et al. Non-invasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer 2006;119:608-14. (Pubitemid 43955715)
15. Chang HW, Chan A, Kwong DL, Wei WI, Sham JS, Yuen AP. Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal brushing and peripheral blood of nasopharyngeal carcinoma patient. Int J Cancer 2003;105:851-5. (Pubitemid 36706111)
16. Hutajulu SH, Indrasari SR, Indrawati LP, Harijadi A, Duin S, Haryana SM, et al., Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer 2011;10:48.
17. Lo YM, Chan LY, Lo KW, Leung SF, Zhang J, Chan AT, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999;59:1188-91. (Pubitemid 29136244)
18. Lo YM, Chan LY, Chan AT, Leung SF, Lo KW, Zhang J, et al. Quantitative and temporal correlation between circulating cell-free Epstein Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 1999;59:5452-5. (Pubitemid 29526455)
19. Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 2002;94:1614-9. (Pubitemid 35378726)
20. Deiman B, Van Aarle P, Sillekens P. Characteristics and applications of nucleic acid sequence-based amplification (NASBA). Mol Biotechnol 2000;20:16379.
21. Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Fachiroh J, Paramita DK, et al. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol 2005;43:3066-73. (Pubitemid 40981304)
22. Stevens SJ, Verkuijlen SA, Middeldorp JM. Quantitative detection of Epstein-Barr virus DNA in clinical specimens by rapid real-time PCR targeting a highly conserved region of EBNA-1. Methods Mol Biol 2005;292:15-26.
23. Hesselink AT, Van den Brule AJC, Groothuismink ZMA, Molano M, Berkhof J, Meijer CJLM, et al. Comparison of three different PCR methods for quantifying HPV16 DNA in cervical scrapes. J Clin Microbiol 2005;43:4868-71. (Pubitemid 41298298)
24. Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, et al. Single-Assay combination of Epstein-Barr virus (EBV) EBNA-1 and viral capsid antigen p18- derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: Options for field screening. J Clin Microbiol 2006;44:1459-67.
25. Hutajulu SH, Ng N, Jati BR, Fachiroh J, Herdini C, Hariwiyanto B, et al. Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia. J Med Virol 2012;84:768-76.
26. Ng WT, Yau TK, Yung RWH, Sze WM, Tsang AHI, Lay ALY. Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer 2005;113:998-1001. (Pubitemid 40096880)
27. Jan YJ, Chen SJ, Wang J, Jiang RS. Liquid-based cytology in diagnosing nasopharyngeal carcinoma. Am J Rhinol Allergy 2009;23:422-5.
28. Le QT, Jones CD, Yau TK, Shirazi HA, Wong PH, Thomas EN, et al. A Comparison study of different PCR assays in measuring circulating Plasma Epstein-Barr virus DNA levels in patients with nasopharyngeal carcinoma. Clin Cancer Res 2005;11:5700-7. (Pubitemid 41170293)
29. Anker P, Mulcahy H, Chen XQ, Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 1999;18:65-73. (Pubitemid 29411092)
30. Chang AR, Liang XM, Chan ATC, Chan MKM, Teo PML, Johnson PJ. The use of brush cytology and directed biopsies for the detection of nasopharyngeal carcinoma and precursor lesions. Head Neck 2001;23:637-45. (Pubitemid 32643107)
31. Chan AT, Ma BB, Lo YM, Leung SF, Kwan WH, Hui EP, et al. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol 2004;22:3053-60. (Pubitemid 41103717)
32. Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, et al. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 2002;8:2612-9. (Pubitemid 34856348)
33. Chan KC, Leung SF, Yeung SW, Chan AT, Lo YM. Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients. Clin Cancer Res 2008;14:4141-5.
34. Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004;350:2461-70. (Pubitemid 38736543)
35. Lin JC, Chen KY, Wang WY, Jan JS, Liang WM, Tsai CS, et al. Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival. J Clin Oncol 2001;19:2607-15. (Pubitemid 32441365)